FEBS Press
Low levels of β-TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin-induced DNA damage via homologous recombination (HR) and promote tumor cell survival....
Muy contentos de que nuestro artículo "β-TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1" haya sido publicado en @moloncology.bsky.social
@ibis-investigacion.bsky.social @sebbm.bsky.social
Aquí os dejamos el link doi.org/10.1002/1878...
29.07.2025 12:30 —
👍 2
🔁 1
💬 0
📌 0
Last Thursday, June 26, our colleague Mónica González Moreno presented her doctoral thesis, in which she evaluated novel combination treatments using Palbociclib and BH3 mimetics in invasive bladder cancer. @ibis-investigacion.bsky.social #HospitalVirgenDelRocio
30.06.2025 12:46 —
👍 1
🔁 0
💬 0
📌 0
Yesterday, our colleagues Jaime Torrente and Laura Rodríguez talked about science to the little ones at the 23rd Science Fair of Seville with the activity 'How do we study diseased tissues?'
@ibis-investigacion.bsky.social #23FeriaCiencia
23.04.2025 11:55 —
👍 1
🔁 1
💬 0
📌 0
El 28 de marzo de 1942, hoy hace 83 años, moría Miguel Hernández en una cárcel franquista...
es.m.wikipedia.org/wiki/Miguel_...
28.03.2025 14:26 —
👍 85
🔁 52
💬 2
📌 0
A few weeks ago in the XXI edition of IBIS Researchers Forum 2025 our colleague Laura Rodríguez presented our latest results "Novel therapeutic combinations to overcome cisplatin in bladder cancer".
@ibis-investigacion.bsky.social
27.03.2025 14:38 —
👍 3
🔁 3
💬 1
📌 1